4//SEC Filing
Fernandes Peter 4
Accession 0001415889-22-012505
CIK 0001600132other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 5:25 PM ET
Size
8.6 KB
Accession
0001415889-22-012505
Insider Transaction Report
Form 4
Fernandes Peter
Chief Regulatory Officer
Transactions
- Tax Payment
Common Stock
2022-12-09$0.93/sh−9,985$9,287→ 22,515 total - Exercise/Conversion
Common Stock
2022-12-09+32,500→ 32,500 total - Exercise/Conversion
Restricted Stock Units
2022-12-09−32,500→ 32,500 total→ Common Stock (32,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock.
- [F2]On January 26, 2022, the reporting person was granted 65,000 restricted stock units, 50% vesting on December 9, 2022 and 50% vesting on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001642618
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 5:25 PM ET
- Size
- 8.6 KB